Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

340
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
340
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

307
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
307
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

317
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
317
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

83.5K
Overview
83.5K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

890
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
890
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

572
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
572

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

CD3+ T-cell count prediction for anti-thymocyte globulin treatment monitorization in kidney transplant recipients: a machine learning model.

Frontiers in medicine·2026
Same author

Once-Weekly Subcutaneous Insulin Efsitora for the Management of Diabetes Mellitus: A Systematic Review and Meta-Analysis Study.

Medeniyet medical journal·2026
Same author

HFpEF Diagnosis: A Challenge in CKD with Current Algorithms.

Life (Basel, Switzerland)·2026
Same author

Heart-Type Fatty Acid-Binding Protein as a Marker of Subclinical Cardiac Dysfunction and Cardiorenal Interaction in Autosomal Dominant Polycystic Kidney Disease.

Life (Basel, Switzerland)·2026
Same author

Linking the exposome to frailty: pathways, mechanisms, clinical implications, and prevention.

European journal of internal medicine·2026
Same author

The evolving field of nephrology: what comes next? A report from the European Renal Association Scientific Advisory Board.

Clinical kidney journal·2026
Same journal

Evidence-Based Medicine versus Personalized Medicine when attempting to block complement in IgA nephropathy.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Impact of immunosuppressive therapy on renal and patient survival in rapidly progressive secondary IgA nephropathy.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Severe Pregnancy-Associated Acute Kidney Injury and Maternal Vulnerability.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Correction to: Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Effect of Semaglutide on Measured vs Estimated Glomerular Filtration Rate.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Beyond Diffusion and Convection: Is Adsorption the Third Dimension of Dialysis?

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 16, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.6K

在移植中补充激活.

Mehmet Kanbay1, Lasin Ozbek2, Mustafa Guldan1

  • 1Division of Nephrology, Department of Medicine, Koç University School of Medicine, Istanbul, Turkey.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
|October 3, 2025
PubMed
概括
此摘要是机器生成的。

向补体系统显示了改善移植存活率的希望. 对补充向疗法的进一步研究对于克服移植方面的挑战和降低排斥率至关重要.

关键词:
在T细胞中介的排斥中.通过抗体介导的排斥.互补系统是互补的系统.延迟的移植功能 延迟的移植功能植入器受伤的伤害缺血-再输血损伤的损伤移植脏移植 移植脏异种移植异种移植

更多相关视频

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.8K
Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

16.9K

相关实验视频

Last Updated: Jan 16, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.6K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.8K
Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

16.9K

科学领域:

  • 免疫学 免疫学 免疫学
  • 移植医学 移植医学
  • 腎臟病學 (nephrology) 是一種醫學專業.

背景情况:

  • 长期移植的存活是移植的重大挑战.
  • 器官稀缺使人们重新对异种移植和新疗法产生兴趣.
  • 补体系统对移植脏的免疫反应产生关键影响,影响损伤和排斥.

研究的目的:

  • 审查补充系统在移植中的作用.
  • 检查最近在移植的补充向疗法的进展.
  • 讨论这些治疗策略的局限性和未来方向.

主要方法:

  • 关于补充系统在移植中的作用的文献综述.
  • 对补充向生物制剂当前临床应用的分析.
  • 讨论治疗策略及其局限性.

主要成果:

  • 补充激活与缺血/反损伤以及和异体移植的排斥有关.
  • 病的高复发率与补充系统调节失调有关.
  • 补充向策略处于早期发展阶段,但显示出有希望的结果.

结论:

  • 了解补充激活对于开发有效的移植策略至关重要.
  • 新的补充向剂为改善移植结果提供了潜力.
  • 为了获得更有效的治疗方法,需要进一步的研究和治疗方法的重新设计.